Form 4 for XTNT Xtant Medical Holdings, Inc.
Accepted 2022-01-18 00:00:00 ET · period of report 2022-01-15 · accession 0001235802-22-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-18 | 2022-01-15 | XTNT | Neils Scott C | Interim Chief Financial Office | A - Grant | $0.00 | +89.0K | 167.1K | +114% | $0 |
| D | 2022-01-18 | 2022-01-15 | XTNT | Neils Scott C | Interim Chief Financial Office | A - Grant | $0.00 | +109.2K | 109.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.000001 par value | 2022-01-15 | A | A | 88,983 | $0.00 | 167,108 | D | — | — | (F1) These shares will vest and be issued with respect to 22,246 shares on each of January 15, 2023, January 15, 2024, and January 15, 2025 and with respect to 22,245 shares on January 15, 2026 pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date. (F2) Includes 78,125 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and 88,983 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan. |
| 2 | Derivative | Stock Option (right to buy) | 2022-01-15 | A | A | 109,164 | $0.00 | 109,164 | D | $0.65 · — to 2032-01-15 | 109,164 Common Stock | (F3) This option vests with respect to 27,291 shares on January 15, 2023 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date. |